Aarti Industries Ltd · NSE:AARTIIND

Aarti Industries — Q3 FY2020 Earnings Presentation

15 slides from Aarti Industries's earnings presentation, Feb 13, 2020

  1. Slide 1: Exchange filing cover letter

    @lffii*,=, Ref. No: AIL/B-39 l2O2OlO4O FebruarY L3,2O2O To, To, Listing/ Compliance Departmen 1. Listing/ ComPliance DePartment BSE LTD. National Stock Exchange of Plnir oze Jeej eebhoY Towers, India Limited Dalal Street, "Exchange Plaza" , Plot No. C I l, Mumbai - 400 001. G Block Bandra-Kurla ComP

  2. Slide 2: Q3 & 9M FY20 Results Presentation

    AARTI INDUSTRIES LIMITED Q3 & 9M FY20 Results Presentation December 2019

  3. Slide 3: Disclaimer

    Disclaimer AARTI INDUSTRIES LIMITED may, from time to time, make written and oral forward looking statements, in addition to statements contained in the company's filings with BSE Limited [BSE] and National Stock Exchange of India Limited [NSE], and our reports to shareholders. The company does not

  4. Slide 4: Agenda

    Agenda 1 | At a glance 2 | Quarterly performance 3

  5. Slide 5: Company Overview

    Company Overview Overview Key Metrics  A leading Speciality Chemicals company in Benzene based derivatives with integrated operations and high level of cost optimization  Established by first generation technocrats in 1984 200+ 400+ 700+ Global Domestic  Pharma operations spanning APIs, intermedi

  6. Slide 6: Key Strengths

    Key Strengths • Global Player in Benzene based Derivatives with Integrated Operations o Strong/Leadership position in key products and processes o Integrated operations across product chain of Benzene and Toluene o Ability to effectively use co-products and generate value-added products • Well Diver

  7. Slide 7: Agenda

    Agenda 1 | At a glance 2 | Quarterly performance 6

  8. Slide 8: Chairman's Message

    Chairman’s Message Commenting on the performance for Q3 FY20, Mr. Rajendra Gogri – Chairman & MD at Aarti Industries Ltd. said, “We are pleased to report another steady performance in Q3, which is well-aligned with the value transition of the business and our longer-term growth plans. Q3 revenues an

  9. Slide 9: Q3 & 9M FY20 P&L (Standalone)

    Q3 & 9M FY20 P&L (Standalone) Particulars Y-o-Y Y-o-Y (Rs. Crore) Q3 FY20 Q3 FY19 Growth Q2 FY20 9M FY20 9M FY19 Growth (%) (%) Gross Income from 1,176.7 1,268.2 -7.2% 1019.0 3,281.9 3,646.2 -10.0% Operations  Substantial margin Exports 485.8 504.3 -3.7% 448.1 1,388.5 1,371.7 1.2% improvement on ac

  10. Slide 10: Q3 & 9M FY20 – Speciality Chemicals (Standalone)

    Q3 & 9M FY20 – Speciality Chemicals (Standalone) Revenue Revenue 1014 2902 1001 2732  Higher margins on account of increasing share of value added and Q3 FY19 Q3 FY20 9M FY19 9M FY20 high margin products  Revenue share of products in Chlorination and Nitration chemistries reduced to 25% in 9M FY20

  11. Slide 11: Q3 & 9M FY20 – Pharma (Standalone)

    Q3 & 9M FY20 – Pharma (Standalone) Revenue Revenue 176 549 513 171  Pharma business revenue higher by 3% YoY in Q3 and higher by 7% in 9M FY20  EBIT margins have seen significant Q3 FY19 Q3 FY20 9M FY19 9M FY20 expansion based on higher contribution from regulated markets and value- added products

  12. Slide 12: Revenue Performance (Consolidated)

    Revenue Performance (Consolidated) Revenue Export Deep engagement with Operating revenues have grown on the back of global customers in CAGR: 13% 1,977 Speciality Chemicals and strong volume growth in key business segments and 1,523 1,596 1,477 Pharma. In addition, some 1,449 1,431 4,705 better prod

  13. Slide 13: EBIT Performance (Consolidated)

    EBIT Performance (Consolidated) EBIT Higher growth relative to CAGR: 21% 932 revenue highlights value 744 addition delivered by AIL 615 663 542 447 FY15 FY16 FY17 FY18 FY19 9M FY20 Speciality Chemicals Pharmacuticals CAGR: 19% 819 CAGR: 33% 113 581 642 102 504 566 79 408 39 48 36 FY15 FY16 FY17 FY18

  14. Slide 14: Contact Us

    Contact Us For further information please log on to www.aarti-industries.com or contact: Mr. Chetan Gandhi / Mr. Raj Sarraf Aarti Industries Limited Tel: +91 22 6797 6666 Email: info@aarti-industries.com Shiv Muttoo / Shruti Joshi CDR India Tel: +91 98335 57572 / +91 75065 67349 Email: shiv@cdr-indi

  15. Slide 15: Thank You

    | PRODUCTIVE [WITH SAF [Sear TL ART SA

Aarti Industries — Q3 FY2020 Earnings Presentation on 6ix